A mini-review of anti-hepatitis B virus activity of medicinal plants

References

• ITC. Market for selected medicinal plants and their derivatives. Geneva: International Trade Centre/UNCTAD/GATT; 1982. p. 206.
   Google Scholar
• Mukhtar M, Arshad M, Ahmad M, et al. Antiviral potentials of medicinal plants. Virus Res. 2008;131:111–120.
   PubMed Web of Science ®Google Scholar
• Amin A, Mousa M. Merits of anti-cancer plants from the Arabian Gulf region. Cancer Ther. 2007;5:55–66.
   Google Scholar
• Hasan MY, Das M, Behjat S. Alternative medicine and the medical profession: views of medical students and general practitioners. East Mediterr Health J. 2000;6:25–33.
   PubMedGoogle Scholar
• Migahid AM. Flora of Saudi Arabia. 4th ed. Riyadh: King Saud University Press; 1996.
   Google Scholar
• Farnsworth NR, Bingel AS. Problems and prospects of discovering new drugs from higher plants by pharmaceutical screening. In: Wagner H, Wolff P, editors. New natural products and plant drugs with pharmacological or therapeutical activity. Berlin: Springer Verlag; 1977. p. 1–22.
   Google Scholar
• Schippmann U, Cunningham AB, Leaman DJ. Impact of cultivation and gathering of medicinal plants on biodiversity: global trends and issues, case study no. 7. In: Biodiversity and the ecosystem approach in agriculture, forestry and fisheries. Satellite event on the occasion of the Ninth Regular Session of the Commission on Genetic Resources for Food and Agriculture. Proceedings; 2002 Oct 12–13; Rome. Rome: FAO Inter-departmental Working Group on Biological Diversity for Food and Agriculture; 2003. Available from: http://www.fao.org/DOCREP/005/Y4586E/y4586e08.htm.
   Google Scholar
• Rahman MA, Mossa JS, Al-Said MS, et al. Medicinal plant diversity in the flora of Saudi Arabia 1: a report on seven plant families. Fitoterapia. 2004;75:149–161.
   PubMed Web of Science ®Google Scholar
• Mossa JS, AI-Yahyu MA, AI-Meshal IA. Medicinal plants of Saudi Arabia. Vol. 1. Riyadh: King Saud University Press; 1987.
   Google Scholar
• Mossa JS, AI-Yahya MA, AI-Meshal IA. Medicinal plants of Saudi Arabia. Vol. 2. Riyadh: King Fahad National Library Publication; 2000.
   Google Scholar
• Koprowski H, Yusibov V. The green revolution: plants as heterologous expression vectors. Vaccine. 2001;19:2735–2741.
   PubMed Web of Science ®Google Scholar
• Glenz K, Warzecha H. New medicinal plants for the production of vaccines. J Verb Leb. 2006;1:126–130.
   Google Scholar
• Hollinger FB, Liang TJ. Hepatitis B virus. In: Knipe DM, Howley PM, editors. Fields’ virology. Philadelphia (PA): Lippincott Williams and Wilkins; 2001. p. 2971–3036.
   Google Scholar
• Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine. 1999;17:1730–1733.
   PubMed Web of Science ®Google Scholar
• Okuda K. Hepatocellular carcinoma. J Hepatol. 2000;32:225–237.
   PubMed Web of Science ®Google Scholar
• Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65–73.
   PubMed Web of Science ®Google Scholar
• Meddrey WC. Hepatitis B: an important public health issue. J Med Virol. 2000;61:362–366.
   PubMed Web of Science ®Google Scholar
• CDC, Hepatitis Branch. Epidemiology and prevention of viral hepatitis A to E: an overview [slide set]. U.S. Department of Health and Human Services, Public Health Service. Atlanta (GA): Centers for Disease Control and Prevention; 1995. Available from: http://virology-online.com/viruses/HepatitisB.htm
   Google Scholar
• Lavanchy D. Hepatitis B virus: epidermiology, disease burden, treatment and current and emerging prevention and control measures. J Viral Hepatitis. 2004;11:97–107.
   PubMed Web of Science ®Google Scholar
• Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology. 1995;22:1863–1873.
   PubMed Web of Science ®Google Scholar
• Al-Faleh FZ. Changing pattern of hepatitis viral infection in Saudi Arabia in the last two decades. Ann Saudi Med. 2003;23(6):367–371.
   PubMed Web of Science ®Google Scholar
• Abdo AA, Karim HA, Al Fuhaid T, et al. Saudi gastroenterology association guidelines for the diagnosis and management of hepatocellular carcinoma: summary of recommendations. Ann Saudi Med. 2006;26:261–265.
   PubMed Web of Science ®Google Scholar
• Jassim SAA, Naji MA. Novel antiviral agents: a medicinal plants perspective. J App Microbiol. 2003;95:412–417.
   PubMed Web of Science ®Google Scholar
• Aljofan M, Netter HJ, Aljarbou AN, et al. Anti-hepatitis B activity of isoquinoline alkaloids of plant origin. Arch Virol. 2014;159:1119–1128.
   PubMed Web of Science ®Google Scholar
• Chantrill BH, Coulthard CE, Dickinson L, et al. The action of plant extracts on a bacteriophage of Pseudomonas pyocyanea and on influenza A virus. J Gen Microbiol. 1952;6:74–84.
   PubMedGoogle Scholar
• Dutra RC, Campos MM, Santos ARS, et al. Medicinal plants in Brazil: pharmacological studies, drug discovery, challenges and perspectives. Pharmacol Res. 2016;112:4–29.
   Google Scholar
• TMR. Nutraceuticals market-global industry analysis, size, share, growth, trends, and forecast 2015–2021 [Internet]. Albany (NY): Transparency Market Research; cTMR [published 2015 Sep 23]. Available from: http://www.transparencymarketresearch.com/globalnutraceuticals-product-market.html
   Google Scholar
• Lahlou M. The success of natural products in drug discovery. Pharmacol Pharm. 2013;4:17–31.
   Google Scholar
• Semple SJ, Reynolds GD, O'Leary MC, et al. Screening of Australian medicinal plants for antiviral activity. J Ethnopharm. 1998;60:163–172.
   PubMed Web of Science ®Google Scholar
• Tolo FM, Rukunga GM, Muli FW, et al. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus. J Ethnopharm. 2006;104:92–99.
   PubMed Web of Science ®Google Scholar
• Abad MJ, Bermejo P, Villar A, et al. Antiviral activity of medicinal plant extracts. Phytother Res. 1997;11:198–102.
   Web of Science ®Google Scholar
• Yang CM, Cheng HY, Lin TC, et al. The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-beta-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection. J Ethnopharm. 2007;110:555–558.
   PubMed Web of Science ®Google Scholar
• Pantev A, Ivancheva S, Staneva L, et al. Biologically active constituents of a polyphenol extract from Geranium sanguineum L. with ant-influenza activity. Z Naturforsch C. 2006;61:508–516.
   PubMed Web of Science ®Google Scholar
• Serkedjieva J. Anti-infective activity of a plant preparation from Geranium sanguineum L. Pharmazie. 1997;52:799–802.
   PubMed Web of Science ®Google Scholar
• Serkedjieva J. Combined antiinfluenza virus effect of a plant preparation and a bacterial protease inhibitor. Biotechnol Biotechnol Equip. 2009;23(Suppl. 1):589–593.
   Google Scholar
• Parida MM, Upadhyay C, Pandya G, et al. Inhibitory potential of neem (Azadirachta indica Juss) leaves on dengue virus type-2 replication. J Ethnopharm. 2002;79:273–278.
   PubMed Web of Science ®Google Scholar
• Felipe AM, Rincao VP, Benati FJ, et al. Antiviral effect of Guazuma ulmifolia and Stryphnodendron adstringens on poliovirus and bovine herpes virus. Biol Pharm Bull. 2006;29:1092–1095.
   PubMed Web of Science ®Google Scholar
• Kott V, Barbini L, Cruanes M, et al. Antiviral activity in Argentine medicinal plants. J Ethnopharm. 1999;64:79–84.
   PubMed Web of Science ®Google Scholar
• Vijayan C, Raghu C, Ashok G, et al. Antiviral activity of medicinal plants of Nilgiris. Indian J Med Res. 2004;120:24–29.
   PubMed Web of Science ®Google Scholar
• Notka F, Meier G, Wagner R. Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral Res. 2004;64:93–102.
   PubMed Web of Science ®Google Scholar
• Barak V, Halperin T, Kalickman I. The effect of sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. Inflammatory cytokines. Eur Cytokine Netw. 2001;12:290–296.
   PubMed Web of Science ®Google Scholar
• Ooi LS, Sun SS, Ooi VE. Purification and characterization of a new antiviral protein from the leaves of Pandanus amaryllifolius (Pandanaceae). Int J Biochem Cell B. 2004;36:1440–1446.
   PubMed Web of Science ®Google Scholar
• Wong DKH, Cheung AM, O'Rourke K, et al. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Inter Med. 1993;119:312–323.
   PubMed Web of Science ®Google Scholar
• Zoulim F. A preliminary benefit-risk assessment of lamivudine for the treatment of chronic hepatitis B virus infection. Drug Safety. 2002;25:497–510.
   PubMed Web of Science ®Google Scholar
• Liu J, Lin H, McIntosh H. Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review. J Viral Hepatitis. 2001;8:358–366.
   PubMed Web of Science ®Google Scholar
• Lee CD, Ott M, Thyagarajan SP, et al. Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication. Eur J Clin Invest. 1996;26:1069–1076.
   PubMed Web of Science ®Google Scholar
• Ott M, Thyagarajan SP, Gupta S. Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors. Eur J Clin Invest. 1997;27:908–915.
   PubMed Web of Science ®Google Scholar
• Huang ZM, Yang XB, Cao WB. Effects of Qin ling ke li in the treatment of 90 patients with chronic hepatitis B. Pharm J Chinese People's Lib Army. 2001;17:41–44.
   Google Scholar
• Jacob JR, Korba BE, You JE, et al. Korean medicinal plant extracts exhibit antiviral potency against viral hepatitis. J Altern Complement Med. 2004;10:1019–1026.
   PubMed Web of Science ®Google Scholar
• Al-Ali KH, El-Badry AA. Anti-viral activity of two labiatae plants [naana (hassoi, habak) and basil (rahan)] of Al-Madiah Al-Munawarah. J Med Biomed Sci. 2010;2:67–73.
   Google Scholar
• Chang JM, Huang KL, Yuan TTT, et al. The anti-hepatitis B virus activity of Boehmeria nivea extract in HBV-viremia SCID mice. Evid Based Complement Alternat Med. 2010;7:189–195.
   PubMed Web of Science ®Google Scholar
• Lam WY, Leung KT, Law PT, et al. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis. J Cell Biochem. 2006;97:795–812.
   PubMed Web of Science ®Google Scholar
• Hussein G, Miyashiro H, Nakamura N, et al. Inhibitory effects of Sudanese medicinal plant extracts on hepatitis C virus (HCV) protease. Phytother Res. 2000;14:510–516.
   PubMed Web of Science ®Google Scholar
• El-Adawi H, El-Demellawy M, El-Wahab AA. Some medicinal plant extracts exhibit potency against viral hepatitis C. J Biosci Tech. 2011;2:223–231.
   Google Scholar
• Zuo GY, Li ZQ, Chen LR, et al. In vitro anti-HCV activities of Saxifraga melanocentra and its related polyphenolic compounds. Antivir Chem Chemother. 2005;16:393–398.
   PubMedGoogle Scholar
• He K, Geng CA, Cao TW, et al. Two new secoiridoids and other anti-hepatitis B virus active constituents from Swertia patens. J Asian Nat Prod Res. 2016;18(6):528–534.
   PubMed Web of Science ®Google Scholar
• Zhou NJ, Geng CA, Huang XY, et al. Anti-hepatitis B virus active constituents from Swertia chirayita. Fitoterapia. 2015;100:27–34.
   PubMed Web of Science ®Google Scholar
• Jiang C, Luo P, Zhao Y, et al. Carolignans from the aerial parts of Euphorbia sikkimensis and their anti-HIV activity. J Nat Prod. 2016;79(3):578–583.
   PubMed Web of Science ®Google Scholar
• Hu XP, Shao MM, Song X, et al. Antiinfluenza virus effects of crude phenylethanoid glycosides isolated from Ligustrum purpurascens via inducing endogenous interferon-γ. J Ethnopharmacol. 2016;179:128–136.
   PubMed Web of Science ®Google Scholar
• Wu YH. Naturally derived anti-hepatitis B virus agents and their mechanism of action. World J Gastroenterol. 2016;22:188–204.
   PubMed Web of Science ®Google Scholar
• Wei PH, Wu SZ, Mu XM, et al. Effect of alcohol extract of Acanthus ilicifolius L. on anti-duck hepatitis B virus and protection of liver. J Ethnopharmacol. 2015;160:1–5.
   PubMed Web of Science ®Google Scholar
• Subashini MS, Rajendran P. In vitro screening of anti HBV and anti HIV properties of Gymnema sylvestre R.Br leaves from Kolli Hills, Tamilnadu, India. Int J Curr Microbiol Appl Sci. 2015;4:542–547.
   Google Scholar
• Jung J, Kim NK, Park S, et al. Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro. BMC Complement Altern Med [Internet]. 2015 [cited 2016 Apr 12];15:255. Available from: http://bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-015-0792-3.
   PubMed Web of Science ®Google Scholar
• Li B, Guo QL, Tian Y, et al. New anti-HBV C-boivinopyranosyl flavones from Alternanthera philoxeroides. Molecules [Internet]. 2016 [cited 2016 Apr 12];21:336. Available from: http://www.mdpi.com/1420-3049/21/3/336.
   PubMed Web of Science ®Google Scholar
• Rechtman MM, Har-Noy O, Bar-Yishay I, et al. Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha. FEBS Lett. 2010;584:2485–2490.
   PubMed Web of Science ®Google Scholar
• Huang TJ, Tsai YC, Chiang SY, et al. Anti-viral effect of a compound isolated from Liriope platyphylla against hepatitis B virus in vitro. Virus Res. 2014;192:16–24.
   PubMed Web of Science ®Google Scholar
• Cui X, Wang Y, Kokudo N, et al. Traditional Chinese medicine and related active compounds against hepatitis B virus infection. BioScience Trends. 2010;4(2):39–47.
   PubMed Web of Science ®Google Scholar